Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05057338
Other study ID # CoreDISTparticipation
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date August 27, 2021
Est. completion date August 30, 2022

Study information

Verified date September 2021
Source Nordlandssykehuset HF
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Multiple Sclerosis (MS) is a chronic disease affecting young adults. Impaired balance, walking, reduced physical activity and participation in employment are common, however, less integrated in the health care. The researchers have developed a multidisciplinary intervention and pathway delivered across health care levels targeting the promotion of balance, walking, physical activity and participation in employment. The research team will perform a pilot feasibility Randomized Controlled Trial (RCT) and interviews to investigate the feasibility of the new intervention compared to a standard care for individuals with lower levels of disability.


Description:

The study addresses core elements in the health services for individuals with MS, constituting approximately 11000 in Norway. The two-armed pilot feasibility-RCT will be performed across the MS-outpatient (MS-OP) clinic, Nordland Hospital Trust, Bodø (NLSH), and in two surrounding municipalities, including 30 employed participants who will be followed for 10-weeks. The new intervention and pathway, CoreDISTparticipation, builds on GroupCoreDIST, which is previously found effective short and long term compared to standard care. CoreDISTparticipation consists of three phases: a) at the MS-OP clinic, in addition to the regular consultations, the patient will have a structured digital conversation with the MS-nurse addressing work related issues and a session with a physiotherapist exploring possibilities for change in balance and walking; b) in the municipality, a physiotherapist will continue exploration of improvements, followed by four weeks of GroupCoreDIST for 60 minutes, 2 times per week supplemented with home exercise programs focusing on balance, walking and physical activity. The participants will have access to exercise programs on videos through an open website at Nord University to digitally support home training. To promote participation in employment, a structured digital meeting between each patient, the MS-nurse, the patient's employer, and the physiotherapist (who leads the group trainings) will take place in phase b; followed by phase c) which include four weeks of outdoor group based exercises and physical activity led by a physiotherapist, for 60 minutes, 2 times per week supplemented with the same home exercise programs as in phase b. Evaluation of employment and physical activity will be conducted using an evaluation form. The control group will receive usual consultations at the MS-OP clinic, as well as a session with a physiotherapist at the MS-OP clinic, exploring possibilities for change in balance and walking. In the municipality the control group will follow standard care (their usual follow-up). The research team will examine feasibility, preliminary between-group differences regarding balance, walking, physical activity level, health related quality of life and barriers in employment, as well as the users' experiences with participation in the CoreDISTparticipation.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 30
Est. completion date August 30, 2022
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 68 Years
Eligibility Inclusion Criteria: - Diagnosed with MS (Mc Donald's criteria), Expanded Disability Status Scale =3.5 (no disability-fully ambulatory with moderate disability), =18 years, being employed. By these criteria the study will include individuals most accessible for the intervention and who have the best prospects to maintain/improve balance, walking, physical activity and participation in employment. Exclusion Criteria: - Retired, pregnancy at enrolment, exacerbation within two weeks prior to enrolment and other serious conditions compromising balance, walking or work capacity.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
CoreDISTparticipation
CoreDISTparticipation is a thorough intervention that contains coordination of services (physiotherapy, MS-nursing and work adaptations) between the MS-OP clinic and the municipality aiming to improve function, physical activity and employment in individuals with MS.
Standard care
The standard care group will follow regular consultations at the MS-outpatient clinic including a session with the physiotherapist. Furthermore, this group will follow usual care in the municipality which might include other forms of physiotherapy or physical activity. These will be registered.

Locations

Country Name City State
Norway Bodø Municipality Bodø
Norway Physiotherapy department, Nordlandssykehuset HF Bodø

Sponsors (4)

Lead Sponsor Collaborator
Nordlandssykehuset HF Hasselt University, Helse Nord, Nord University

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary MS Work Difficulties Questionnaire-23 How frequently individuals with MS perceive psychological/cognitive (11 items)-, physical (8 items)- and external barriers (4 items) related to their current or most recent job, and is scored by a five point scale (best score 0). (Recently translated to Norwegian). Baseline
Primary Six-Minutes Walk Test Walking distance within six minutes Baseline
Primary MS Work Difficulties Questionnaire-23 How frequently individuals with MS perceive psychological/cognitive (11 items)-, physical (8 items)- and external barriers (4 items) related to their current or most recent job, and is scored by a five point scale (best score 0). (Recently translated to Norwegian). 5 weeks post-test
Primary Six-Minutes Walk Test Walking distance within six minutes 5 weeks post-test
Primary MS Work Difficulties Questionnaire-23 How frequently individuals with MS perceive psychological/cognitive (11 items)-, physical (8 items)- and external barriers (4 items) related to their current or most recent job, and is scored by a five point scale (best score 0). (Recently translated to Norwegian). 10 week post-test
Primary Six-Minutes Walk Test Walking distance within six minutes 10 week post-test
Secondary Trunk Impairment Scale Norwegian Version Dynamic sitting balance, 6 items, top score 16. Baseline
Secondary Mini Balance Evaluation Systems Test Pro-and reactive balance, dual task and involving sit to stand, standing and walking, 14 items on a 3 point with a top score of 28 Baseline
Secondary Force Platform The force platform measures control in standing: symmetry/asymmetry of weight bearing with eyes open/closed, postural sway of center of pressure, and weight transfer which all together will present an outcome for standing balance. Baseline
Secondary Activity monitors outcome 1 The monitors measure Physical activity levels (inactive, light, moderate, vigorous) within 7 days Baseline
Secondary Activity monitors outcome 2 The monitors measure number of steps within 7 days Baseline
Secondary European Quality of Life 5-Dimension-3 Level Self-perceived health related quality of life regarding five domains, each with three items, and a Visual Analog Scale (0-100) recording perceived health. Baseline
Secondary Multiple Sclerosis Walking Scale-12 Limitations in walking due to MS on 12 items with a scale 1-5, best score 12 Baseline
Secondary Multiple Sclerosis Impact Scale-29 Self-perceived physical (13 items) and psychological (9 items) impact due to MS on health related quality of life recorded by a five point scale (best score 29) baseline
Secondary Weight Self reported weight by kilogram baseline
Secondary Height Self reported height by centimetre baseline
Secondary age Self reported age by years baseline
Secondary Social status Self reported social status; married, cohabitant, living alone baseline
Secondary Type of multiple sclerosis Self reported main types: relapsing remitting, primary progressive, secondary progressive baseline
Secondary Year of diagnosis multiple sclerosis Self reported by year baseline
Secondary Medications Self reported by type of medications baseline
Secondary Expanded disability status scale Self reported or from journal functional status at last yearly control by a neurologist baseline
Secondary Occupation Self reported baseline
Secondary Percentage of work Self reported percentage of work the previous month baseline
Secondary Length of education Self reported choices: elementary school; high school; bachelor; masters degree; Doctor of philosophy degree baseline
Secondary Trunk Impairment Scale Norwegian Version Dynamic sitting balance, 6 items, top score 16. 5 weeks post-test
Secondary Mini Balance Evaluation Systems Test Pro-and reactive balance, dual task and involving sit to stand, standing and walking, 14 items on a 3 point with a top score of 28 5 weeks post-test
Secondary Force Platform The force platform measures control in standing: symmetry/asymmetry of weight bearing with eyes open/closed, postural sway of center of pressure, and weight transfer which all together will present an outcome for standing balance. 5 weeks post-test
Secondary Activity monitors outcome 1 The monitors measure Physical activity levels (inactive, light, moderate, vigorous) within 7 days 5 weeks post-test
Secondary Activity monitors outcome 2 The monitors measure number of steps within 7 days 5 weeks post-test
Secondary European Quality of Life 5-Dimension-3 Level Self-perceived health related quality of life regarding 5 weeks post-test
Secondary Multiple Sclerosis Walking Scale-12 Limitations in walking due to MS on 12 items with a scale 1-5, best score 12 5 weeks post-test
Secondary Multiple Sclerosis Impact Scale-29 Self-perceived physical (13 items) and psychological (9 items) impact due to MS on health related quality of life recorded by a five point scale (best score 29) 5 weeks post-test
Secondary Percentage of work Self reported percentage of work 5 weeks post-test
Secondary Trunk Impairment Scale Norwegian Version Dynamic sitting balance, 6 items, top score 16. 10 weeks post-test
Secondary Mini Balance Evaluation Systems Test Pro-and reactive balance, dual task and involving sit to stand, standing and walking, 14 items on a 3 point with a top score of 28 10 weeks post-test
Secondary Force Platform The force platform measures control in standing: symmetry/asymmetry of weight bearing with eyes open/closed, postural sway of center of pressure, and weight transfer which all together will present an outcome for standing balance. 10 weeks post-test
Secondary Activity monitors outcome 1 The monitors measure Physical activity levels (inactive, light, moderate, vigorous) within 7 days 10 weeks post-test
Secondary Activity monitors outcome 2 The monitors measure number of steps within 7 days 10 weeks post-test
Secondary European Quality of Life 5-Dimension-3 Level Self-perceived health related quality of life regarding 10 weeks post-test
Secondary Multiple Sclerosis Walking Scale-12 Limitations in walking due to MS on 12 items with a scale 1-5, best score 12 10 weeks post-test
Secondary Multiple Sclerosis Impact Scale-29 Self-perceived physical (13 items) and psychological (9 items) impact due to MS on health related quality of life recorded by a five point scale (best score 29) 10 weeks post-test
Secondary Percentage of work Self reported percentage of work 10 weeks post-test
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis